Introduction Despite advances in pharmacologic strategies and updates in evidence-based treatment guidelines, primary care clinicians face a host of challenges in diagnosing and managing patients with gastroesophageal reflux disease (GERD). In addition, clinicians must be able to identify a variety of GERD patient types and address the unique needs of each individual. A recent survey of US-based primary care physicians showed that there is much confusion about various aspects of GERD diagnosis and treatment. This evidence-based activity will outline and discuss the importance of the patient-clinician relationship in managing GERD and will arm clinicians with important questions to ask their patients in a variety of fundamental areas, ranging from symptoms to concomitant medication use. Implementing better communication strategies can help empower primary care clinicians to improve their overall management in GERD patients. Expert faculty will discuss common GERD cases that clinicians may face in a practical 1-hour home study activity. This activity will also provide participants the opportunity to develop effective management and ongoing care strategies for implementation in the individual GERD patient. Target Audience This will be a 1-hour activity accredited for physicians, nurse practitioners, physician assistants, nurses, and pharmacists. There is no fee to participate in this activity. Learning Objectives After completion of this activity, the participant should be better able to:
In accordance with the ACCME, TCL Institute, LLC requires that any person who is in a position to control the content of a CME activity must disclose all relevant financial relationships they have with a commercial interest. Accordingly: Dr. Watkins has nothing to disclose. The NCAFP staff and TCL Institute, LLC staff that were involved in the development of this activity have no financial relationships with any commercial interests that are relevant to this activity. To resolve identified conflicts of interest, the educational content was fully peer-reviewed by a physician member of the TCL Institute, LLC Content Review Committee who has nothing to disclose. The resulting certified activity was found to provide educational content that is current, evidence-based, and commercially balanced.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Takeda Pharmaceuticals North America, Inc.; TCL Institute, LLC; or the NCAFP. This material is prepared based upon a review of multiple sources of information, but it is not exhaustive of the subject matter. Therefore, health care professionals and other individuals should review and consider other publications and materials on the subject matter before relying solely upon the information contained within this educational activity. 
|
Purdue University School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is an application-based continuing education activity of Purdue University, an equal access/equal opportunity institution. Universal Program (UPN): 0018-9999-09-242-H01-P, 1.0 contact hours (0.1 CEUs).
